Beijing Wanjie Medical Device Co., Ltd. recently announced the successful completion of a B-round financing of nearly 100 million yuan. The round was invested by the fund under CAS Investment Management Co., Ltd., with Mailin Capital serving as the exclusive financial advisor. The funds raised will be mainly used for product research and development in the fields of orthopedic minimally invasive and tissue regeneration, accelerating product commercialization, and iterative development of mature products.
Company Background and Achievements
Since its establishment, Wanjie Medical Device has won the continuous favor and support of many professional investment institutions such as Yilian Capital, thanks to its outstanding technical strength and development potential, and has steadily moved forward with the help of capital. Zhang Mei, founder of Wanjie Medical Device, said, “Thank you to Mailin Capital for your help in this round of financing. In the current highly uncertain capital market environment, you have helped Wanjie Medical Device successfully complete this round of financing and provided all-round support to the company in many aspects such as capital planning, government relations, and key customers. I wish Mailin Capital continued success!”
Wanjie Medical Device, founded in 2006, is a high-tech enterprise integrating R & D, production, sales, and foreign trade, headquartered in the Zhongguancun Medical Device Industrial Park, known as the “China Pharmaceutical Valley.” Throughout its development, Wanjie Medical Device has been elected as the vice-chairman unit of the China Sports Medicine Industry-University-Research Innovation Alliance, approved to establish a post-doctoral research workstation, and has been recognized as a Beijing Specialized, Precise, Special, and New “Little Giant” Enterprise, a Beijing Patent Pilot Unit, and one of the top 20 comprehensive R & D strength enterprises in China’s medical device industry, receiving recognition from all sides of the industry.
Product Portfolio and Market Coverage
Wanjie Medical Device is committed to becoming a leading enterprise in the field of orthopedic minimally invasive and tissue regeneration, focusing on orthopedic minimally invasive (sports medicine, spinal minimally invasive, joint surgery), tissue repair and regeneration, and medical aesthetics. Its product matrix covers a wide range of products in emerging orthopedic fields, including 4K medical endoscope camera systems, joint arthroscopes, intervertebral foramen mirrors, plasma surgical equipment, medical pulse irrigation and drainage devices, meniscal suture systems, adjustable titanium plate systems with loops, suture anchor nails, rich-platelet plasma preparators, and medical bone cement. These products have been widely recognized by many clinical doctors.
So far, Wanjie Medical Device has applied for more than 60 patents in total and has obtained 46 medical device registration certificates. Its core products have achieved full coverage in 32 provinces, with more than 2,000 supply partners, and have entered more than 2,200 hospitals, with a coverage rate of over 80% in tertiary hospitals. It has also established scientific research cooperation relationships with Peking University Third Hospital, General Hospital of the People’s Liberation Army, and Shanghai Sixth People’s Hospital.
Future Prospects
Amidst the national trend of comprehensive centralized procurement of medical devices, Wanjie Medical Device continues to forge ahead with a fighting spirit, without limits or fears. It insists on taking R & D innovation as the core driving force, deeply cooperates with many domestic R & D institutions, medical institutions, and renowned experts, gathers professional talents from various fields, and relies on an advanced production system to build a unique industry-university-research-medical innovation system of Wanjie Medical Device. By leveraging the industry-university-research-medical cooperation platform, it can timely grasp the innovative direction of industry development, promote the transformation and implementation of scientific and technological achievements, accelerate product upgrades and iterations, and continuously launch medical consumables, equipment, and tools with technological leadership, so as to benefit more patients with domestic medical devices.-Fineline Info & Tech
Leave a Reply